BRCA
  • About Us
    • Leadership
    • Scientific Advisory Committee
    • Impact Reports
    • Press Releases
  • Grants
    • Research Program
    • Previously Funded Grants
    • Key Research References
  • Resources
    • FAQ: Living with BRCA
    • TARGET: A Genetic Education Webtool
    • Knowledge Center
    • Clinical Trials
  • News
  • Contact

23andMe Cleared to Report 41 More BRCA Mutations

Posted OnAugust 31, 2023 byPriscilla Kennedy

The FDA is allowing 23andMe to report 41 more BRCA1 and BRCA2 mutations in its genetic test results.

 

Read the Complete Article Here
Previous PostFDA approves niraparib and abiraterone acetate plus prednisone for BRCA-mutated metastatic castration-resistant prostate cancer
Next Post2024 Funding Announcement
  • Facebook Twitter Bluesky Linkedin Instagram
    • About Us
    • Press
    • Resources
    • News
    • Privacy Policy
  • Contact
  • © 2025 CureBRCA